Literature DB >> 19415591

Tretinoin overdose: a first case report.

Adeline Su-Yin1, Joyce Wong, Timothy Wiegand, Kent Olson.   

Abstract

INTRODUCTION: Tretinoin (Vesanoid) is an all-trans-retinoic acid, and is related to retinol (Vitamin A). To date, there have been several case reports on overdose with its isomer isotretinoin, but none involving overdose of tretinoin. We report the first known case of a patient who ingested a massive overdose of tretinoin. CASE REPORT: A 31-year-old man ingested 1000 mg of tretinoin (100 pills of Vesanoid 10 mg) in a suicide attempt. He developed nonbloody diarrhea, but otherwise had no complaints. Clinical examination was normal. The patient was treated with activated charcoal and was hydrated. The patient's blood results did not show any deterioration on the third consecutive day. He was discharged well on the third day, but was subsequently lost to follow-up. DISCUSSION: Although there has been no reported experience with acute tretinoin overdose in humans, our patient took a dose approximately 3 times the recommended maximum tolerated daily dose in patients with myelodysplastic syndrome or solid tumors (195 mg/m2 per day). Overdose with other retinoids such as isotretinoin have been associated with only minor symptoms that resolved quickly. Our patient had diarrhea, which also resolved quickly with symptomatic treatment and hydration.
CONCLUSION: We believe this to be the first case report of an acute oral overdose of tretinoin. The patient developed diarrhea, but was otherwise asymptomatic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415591      PMCID: PMC3550323          DOI: 10.1007/bf03161091

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  18 in total

1.  Acute hepatomegaly with severe liver toxicity due to all-trans-retinoic acid.

Authors:  G Perea; A Salar; A Altés; S Brunet; J Sierra
Journal:  Haematologica       Date:  2000-05       Impact factor: 9.941

2.  Deliberate self-poisoning with isotretinoin.

Authors:  N C Hepburn
Journal:  Br J Dermatol       Date:  1990-06       Impact factor: 9.302

3.  All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

Authors:  S Castaigne; C Chomienne; M T Daniel; P Ballerini; R Berger; P Fenaux; L Degos
Journal:  Blood       Date:  1990-11-01       Impact factor: 22.113

4.  Overdose of isotretinoin.

Authors:  J D Sutton
Journal:  J Am Acad Dermatol       Date:  1983-10       Impact factor: 11.527

Review 5.  Future trends: a new generation of retinoids.

Authors:  R A Chandraratna
Journal:  J Am Acad Dermatol       Date:  1998-10       Impact factor: 11.527

6.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

Authors:  M E Huang; Y C Ye; S R Chen; J R Chai; J X Lu; L Zhoa; L J Gu; Z Y Wang
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

7.  Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

Authors:  R P Warrell; S R Frankel; W H Miller; D A Scheinberg; L M Itri; W N Hittelman; R Vyas; M Andreeff; A Tafuri; A Jakubowski
Journal:  N Engl J Med       Date:  1991-05-16       Impact factor: 91.245

8.  Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.

Authors:  J Muindi; S R Frankel; W H Miller; A Jakubowski; D A Scheinberg; C W Young; E Dmitrovsky; R P Warrell
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

9.  Isotretinoin ingestion in a pediatric patient.

Authors:  D W Munter; J A Wilkinson
Journal:  J Emerg Med       Date:  1988 Jul-Aug       Impact factor: 1.484

10.  Isotretinoin intoxication in attempted suicide.

Authors:  H Lindemayr
Journal:  Acta Derm Venereol       Date:  1986       Impact factor: 4.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.